Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Tubulin beta class I protein is encoded by the TUBB gene located on chromosome 6p21.33. It forms heterodimers with alpha-tubulins to constitute the main structural components of microtubules—dynamic cylindrical polymers essential for intracellular transport, cell division (mitosis), and maintenance of cell shape in eukaryotes. Each monomer binds GTP: alpha-tubulins bind non-exchangeable GTP while beta-tubulins bind exchangeable GTP that can be hydrolyzed during polymerization/depolymerization cycles. Mutations in TUBB can lead to severe neurodevelopmental disorders such as cortical dysplasia complex with other brain malformations 6 and rare congenital skin conditions like symmetric circumferential skin creases. The protein is a therapeutic target primarily through its role as part of the broader tubulin family targeted by anti-mitotic chemotherapeutics such as taxanes and vinca alkaloids.
Inhibition of microtubule dynamics by stabilizing or destabilizing microtubules leading to cell cycle arrest and apoptosis in rapidly dividing cells such as cancer cells
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin beta class I (TUBB).